跳至主要内容
临床试验/NCT03302689
NCT03302689Unknown不适用

The Double-blind, Randomized Controlled Trial: Comparison of Levobupivacaine and Ropivacaine for Postoperative Analgesia TAP-block After Caesarean Section

Alexandr Ronenson1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年9月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
Level of pain

研究概览

简要总结

Randomized, double-blind, controlled trial: a comparison of Levobupivacaine and Ropivacaine for postoperative analgesia using TAP-block

Objectives:

  1. VAS score during the first 12 hours
  2. Determine which drug is more effective for postoperative analgesia in the first 12 hours after surgery
  3. Side effects

详细描述

For TAP-block was used Hirokain® (Levobupivacaine) . Injectable solution 7.5 mg / ml; ampoule polypropylene 10 ml, a pack of cardboard 10; No. ЛП-003106, 2015-07-21 to 2020-07-21 from EbbVi Ltd. (Russia); manufacturer: Kurida AS (Norway); Packer: AbbVi S.r.l. (Italy), or Ropivacaine Kabi (Ropivacaine Kabi) (Ropivacaine) Solution for injection 7.5 mg / ml; ampoule polypropylene 1 10 ml, a pack of cardboard 5; EAN code: 4607085481524; No. ЛП-002897, 2015-03-04 to 2020-03-04 from Fresenius Kabi Deutschland GmbH (Germany); manufacturer: Fresenius Kabi Norge (Norway).

Both preparations were diluted to a volume of 50 ml, at a concentration of 3 mg / ml.

It was performed by TAP-block in-plain with a 22G needle Quincke, on both sides, and 25 ml on each side was injected.

The pain syndrome was assessed with admission, and every 2 hours during the first 12 hours after the operation, using a digital scale on the VAS.

All patients received NSAIDs (Ketorol 3 mg IV every 6 hours from admission)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Women after the operation do not know what drug they injected with TAP-block The researcher does not know what type of drug is injected

入排标准

性别
Female
接受健康志愿者

入选标准

  • Cesarean section pfannenstiel incision under spinal anesthesia
  • Spinal anesthesia with Bupivacaine heavy 0,5%
  • Without any adjuvants

排除标准

  • Any other anesthesia exept spinal
  • Any other surgical incision

研究组 & 干预措施

Ropivacaine

Experimental

TAP-block with Ropivacaine Solution

干预措施: Ropivacaine Solution (Drug)

Levobupivacaine

Experimental

TAP-block with Levobupivacaine Solution

干预措施: Levobupivacaine Solution (Drug)

结局指标

主要结局

Level of pain

时间窗: 12 hours

Measurement of pain on a VAS scale (from 0 to 10 points)

次要结局

  • The need for additional analgesics (Paracetamol, Tramadol)(12 hours)

研究者

发起方
Alexandr Ronenson
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Alexandr Ronenson

Head of department of Anaesthesiology and Intensive Care Unit

Tver Regional Perinatal Center

研究点 (1)

Loading locations...

相似试验